Search results for "NAFLD"
Serum ferritin values may improve risk stratification of MASLD patients
Baseline hyperferritinemia occurred in almost one-third of study patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and was associated with higher stages of fibrosis.
https://gastroenterology.acponline.org/archives/2024/01/26/3.htm
26 Jan 2024
Clinical practice update offers recommendations on noninvasive testing for NAFLD
Noninvasive tests have the potential to significantly enhance the care of patients with nonalcoholic fatty liver disease (NAFLD) by improving detection of advanced fibrosis, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/08/25/1.htm
25 Aug 2023
Noninvasive methods as good as biopsy for NAFLD prognosis, meta-analysis finds
An analysis of patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) compared the prognostic value of liver stiffness measured by vibration-controlled transient elastography, fibrosis-4 index, and NAFLD fibrosis score.
https://gastroenterology.acponline.org/archives/2023/06/23/1.htm
23 Jun 2023
NASH management conflicts with guidelines in real-world setting, study finds
Researchers sought to learn how patient characteristics vary by stages of liver scarring and how U.S. physicians manage nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2023/05/26/2.htm
26 May 2023
Spotlight on statins and chronic liver disease
Recent studies found associations between statin use and decreased risks of severe liver disease and mortality in patients with chronic liver disease.
https://gastroenterology.acponline.org/archives/2023/05/26/5.htm
26 May 2023
New practice guidance released for NAFLD
The recommendations from the American Association for the Study of Liver Diseases cover the clinical assessment and management of patients with nonalcoholic fatty liver disease (NAFLD).
https://gastroenterology.acponline.org/archives/2023/03/24/1.htm
24 Mar 2023
Heart failure risk increased in patients with NAFLD, meta-analysis finds
Nonalcoholic fatty liver disease (NAFLD) was associated with a 50% increased risk of new-onset heart failure, independent of age, sex, diabetes, hypertension, and other common cardiovascular risk factors, according to an international meta-analysis.
https://gastroenterology.acponline.org/archives/2022/08/26/2.htm
26 Aug 2022
Review examines drugs, lifestyle treatments for NAFLD
The umbrella review included 27 meta-analyses of randomized controlled trials examining the effectiveness of pharmacological interventions and lifestyle modifications, including diet and exercise, for patients with nonalcoholic fatty liver disease (NAFLD).
https://gastroenterology.acponline.org/archives/2022/05/27/2.htm
27 May 2022
Spotlight on NAFLD outcomes
Recent studies found associations between nonalcoholic fatty liver disease (NAFLD) and coronary artery disease, sarcopenia, and mortality.
https://gastroenterology.acponline.org/archives/2022/05/27/5.htm
27 May 2022
Noninvasive score for fibrotic NASH designed for, validated in primary care settings
Levels of aspartate aminotransferase, high-density lipoprotein cholesterol, and HbA1c can be used to predict which patients might need referral to a subspecialist for fibrotic nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2022/04/22/1.htm
22 Apr 2022